Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST000321)

(Analysis AN000510)

Metabolite	Structure	F1	F2	F3	F4
SM (d42:1)	ME114213	0.79	1.39	0.77	1.61
SM (d42:2)	ME114214	0.73	1.29	0.73	1.91
SM (d41:1)	ME114212	0.95	0.95	0.84	1.92
LPC (20:4)	ME114138	0.80	0.97	1.07	1.44
SM (d40:1)	ME114211	0.88	1.03	0.86	1.56
PC (42:7)	ME114178	1.07	NA	0.93	NA
PC (p-44:4) or PC (o-44:5)	ME114197	1.02	NA	0.98	NA
PE (p-40:5) or PE (o-40:6)	ME114204	1.08	0.59	0.98	NA
PC (p-40:5) or PC (o-40:6)	ME114192	1.14	0.57	1.08	0.45
PC (p-42:3) or PC (o-42:4)	ME114194	1.23	0.62	1.06	0.46
CE (18:2)	ME114119	1.15	0.74	1.03	0.56
Ceramide (d42:2)	ME114122	1.20	0.68	1.09	0.66
PC (42:5)	ME114177	1.33	0.28	1.06	0.34
PC (p-40:3) or PC (o-40:4)	ME114190	1.31	0.47	1.15	0.35
LPC (16:0)	ME114132	1.07	0.20	1.82	0.19
LPC (o-16:0)	ME114139	0.96	0.24	1.55	0.23
LPC (16:1)	ME114133	0.79	0.19	1.45	0.32
LPC (p-18:0) or LPC (o-18:1)	ME114140	0.84	0.11	1.35	0.23
PE (p-36:4) or PE (o-36:5)	ME114201	1.40	0.05	1.35	0.02
PE (p-38:4) or PE (o-38:5)	ME114202	1.56	0.07	1.49	0.04
DG (38:5)	ME114129	1.26	NA	0.99	0.38
TG (42:1)	ME114215	0.89	NA	1.19	0.46
DG (38:6)	ME114130	1.00	NA	1.15	0.48
LPC (20:1)	ME114137	0.96	NA	1.10	0.39
PC (30:1)	ME114142	1.09	NA	1.08	0.51
PC (p-38:2) or PC (o-38:3)	ME114186	1.00	NA	1.14	0.59
PC (p-40:4) or PC (o-40:5)	ME114191	0.98	NA	1.05	0.75
PC (p-42:5) or PC (o-42:6)	ME114196	1.10	NA	0.96	0.62
PC (36:1)	ME114159	1.33	0.14	1.39	0.49
PC (33:2)	ME114149	1.28	0.10	1.44	0.53
PC (34:1)	ME114151	1.27	0.13	1.43	0.53
PC (33:1)	ME114148	1.25	0.04	1.44	0.60
PC (35:1)	ME114155	1.26	0.13	1.36	0.65
TG (48:0)_2	ME114219	1.31	0.10	1.35	0.61
Acylcarnitine C16:0	ME114116	1.16	0.25	1.47	0.56
Acylcarnitine C18:0	ME114117	1.19	0.22	1.35	0.50
PC (34:0)	ME114150	1.30	0.33	1.39	0.41
PC (p-38:3) or PC (o-38:4)	ME114187	1.30	0.21	1.39	0.38
PC (34:2)	ME114152	1.29	0.23	1.43	0.44
PC (32:0)	ME114144	1.27	0.28	1.42	0.45
PC (36:2)	ME114160	1.27	0.26	1.42	0.45
PC (37:4)	ME114166	1.32	0.27	1.25	0.44
PC (38:4)	ME114169	1.38	0.31	1.33	0.39
LPC (18:0)	ME114134	1.27	0.14	1.67	0.17
PC (30:0)	ME114141	1.30	0.14	1.56	0.28
LPC (18:1)	ME114135	1.18	0.18	1.59	0.29
PC (31:0)	ME114143	1.22	0.13	1.62	0.32
PC (p-36:3) or PC (o-36:4)	ME114185	1.33	0.10	1.43	0.18
PC (p-38:4) or PC (o-38:5)	ME114188	1.37	0.08	1.38	0.23
PC (32:1)	ME114145	1.40	0.07	1.42	0.39
PC (p-34:1) or PC (o-34:2)	ME114182	1.32	0.10	1.47	0.30
PC (34:3)	ME114153	1.31	0.14	1.49	0.37
SM (d34:1)	ME114208	1.29	0.19	1.47	0.39
PC (35:2)	ME114156	1.36	0.13	1.47	0.34
PC (p-34:0) or PC (o-34:1)	ME114181	1.34	0.14	1.44	0.39
PC (36:4)	ME114162	1.41	0.15	1.44	0.28
PC (38:3)	ME114168	1.39	0.18	1.40	0.36
PE (34:2)	ME114198	1.44	0.06	1.24	0.60
PE (p-38:5) or PE (o-38:6)	ME114203	1.46	0.12	1.21	0.17
PC (32:2)	ME114146	1.37	0.12	1.32	0.45
PC (38:2)	ME114167	1.41	0.16	1.23	0.42
PC (38:6)	ME114171	1.40	0.21	1.20	0.45
SM (d34:0)	ME114207	1.43	0.26	1.29	0.30
PC (36:3)	ME114161	1.49	0.19	1.34	0.29
PC (38:5)	ME114170	1.51	0.22	1.29	0.31
DG (36:3)	ME114127	1.54	0.22	1.19	0.43
DG (36:4)	ME114128	1.53	0.28	1.22	0.35
TG (48:0)_1	ME114218	1.05	0.37	1.53	0.56
Acylcarnitine C18:1	ME114118	1.00	0.28	1.44	0.69
PC (33:0)	ME114147	1.03	0.22	1.29	0.67
PE (38:4)	ME114200	1.37	0.38	1.07	0.74
TG (50:0)	ME114225	1.44	0.34	1.03	0.73
PC (34:4)	ME114154	1.18	0.25	1.07	0.52
PC (35:4)	ME114158	1.14	0.19	1.18	0.59
PC (40:4)	ME114172	1.18	0.17	1.12	0.66
PC (p-36:1) or PC (o-36:2)	ME114183	1.21	0.18	1.28	0.72
PC (35:3)	ME114157	1.27	0.13	1.25	0.72
PC (40:5)	ME114173	1.29	0.16	1.22	0.69
SM (d33:1)	ME114206	1.14	0.31	1.26	0.77
PC (40:7)	ME114175	1.31	0.30	1.15	0.65
PC (p-36:2) or PC (o-36:3)	ME114184	1.27	0.27	1.31	0.61
PC (37:2)	ME114164	1.22	0.32	1.21	0.70
PC (40:6)	ME114174	1.22	0.30	1.25	0.66
PC (37:3)	ME114165	1.23	0.30	1.26	0.69
PE (36:1)	ME114199	1.25	0.30	1.27	0.68
Ceramide (d42:1)_2	ME114121	0.99	1.11	1.12	0.65
LPC (18:2)	ME114136	0.96	0.67	1.26	0.88
PC (36:5)	ME114163	1.01	0.97	0.97	1.03
TG (52:0)	ME114234	1.11	0.83	1.07	0.83
PC (p-40:6) or PC (o-40:7)	ME114193	1.04	0.91	1.00	0.91
SM (d32:1)	ME114205	1.03	0.83	1.08	0.92
TG (44:1)	ME114216	1.24	0.82	0.78	1.24
DG (36:1)	ME114125	1.14	0.45	0.99	0.84
DG (40:7)	ME114131	1.18	0.51	0.95	1.24
PC (p-42:4) or PC (o-42:5)	ME114195	1.06	0.62	0.97	1.18
Ceramide (d42:1)_1	ME114120	0.98	0.60	1.11	1.07
SM (d34:2)	ME114209	0.92	0.63	1.13	1.10
PC (40:8)	ME114176	1.08	0.53	1.02	1.03
SM (d36:1)	ME114210	1.11	0.39	1.12	1.11
PC (p-32:0) or PC (o-32:1)	ME114180	1.11	0.20	0.88	1.54
TG (49:0)	ME114222	1.01	0.42	1.04	1.41
PC (o-34:0)	ME114179	1.00	0.33	1.11	1.26
PC (p-38:5) or PC (o-38:6)	ME114189	0.97	0.29	1.18	1.36
TG (54:8)	ME114251	1.38	1.02	0.82	0.64
TG (58:3)	ME114259	1.33	0.76	0.80	0.94
TG (56:1)	ME114252	1.36	0.76	0.83	0.85
TG (58:2)	ME114258	1.39	0.75	0.79	0.83
TG (54:1)	ME114244	1.46	0.63	0.72	0.96
TG (56:2)	ME114253	1.54	0.67	0.75	0.74
TG (58:4)	ME114260	1.49	0.70	0.73	0.80
TG (58:1)	ME114257	1.39	0.78	0.92	0.68
TG (60:2)	ME114261	1.46	0.80	0.87	0.65
TG (54:7)	ME114250	1.52	0.74	0.92	0.53
TG (54:5)	ME114248	1.54	0.61	0.91	0.59
TG (54:6)	ME114249	1.57	0.64	0.92	0.50
DG (36:2)	ME114126	1.67	0.24	1.07	0.39
DG (34:1)	ME114123	1.69	0.20	0.95	0.58
DG (34:2)	ME114124	1.54	0.25	1.08	0.57
TG (52:6)	ME114240	1.70	0.57	0.53	0.93
TG (52:5)	ME114239	1.74	0.52	0.76	0.57
TG (56:5)	ME114256	1.64	0.35	0.84	0.66
TG (52:4)	ME114238	1.59	0.51	0.89	0.61
TG (54:4)	ME114247	1.60	0.51	0.82	0.68
TG (56:3)	ME114254	1.84	0.32	0.62	0.72
TG (52:1)	ME114235	1.78	0.36	0.58	0.88
TG (54:2)	ME114245	1.83	0.44	0.57	0.78
TG (56:4)	ME114255	1.74	0.28	0.69	0.81
TG (52:2)	ME114236	1.70	0.34	0.69	0.86
TG (53:4)	ME114243	1.67	0.37	0.68	0.87
TG (51:4)	ME114233	1.58	0.43	0.72	0.89
TG (54:3)	ME114246	1.65	0.46	0.72	0.80
TG (46:0)	ME114217	1.57	0.32	0.86	0.80
TG (52:3)	ME114237	1.59	0.38	0.80	0.83
TG (50:1)	ME114226	1.66	0.18	0.78	0.88
TG (50:2)	ME114227	1.64	0.26	0.81	0.82
TG (50:3)	ME114228	2.19	0.09	0.35	0.81
TG (48:1)	ME114220	1.95	0.21	0.48	0.89
TG (48:2)	ME114221	2.10	0.19	0.31	0.92
TG (50:4)	ME114229	2.01	0.18	0.35	1.01
TG (53:2)	ME114241	1.42	0.36	0.67	1.42
TG (51:1)	ME114230	1.60	0.24	0.52	0.99
TG (49:2)	ME114224	1.56	0.29	0.55	1.34
TG (49:1)	ME114223	1.58	0.30	0.59	1.16
TG (51:3)	ME114232	1.76	0.24	0.49	1.21
TG (51:2)	ME114231	1.70	0.26	0.51	1.27
TG (53:3)	ME114242	1.68	0.27	0.54	1.23

Factors:

F1	Treatment:Alcoholic cirrhosis infusion
F2	Treatment:Germ Free Control
F3	Treatment:LGG Treated
F4	Treatment:Normal Human Infusion

Data matrix